Advertisements


Eli Lilly"s Trulicity shows promise in delivering efficacy in type 2 diabetes

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 23rd, 2018

Study of Lilly"s Humulin R U-500 shows improved response in type 2 diabetes

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 25th, 2018

Lilly plans Elanco IPO, posts quarterly profit above estimates

Eli Lilly and Co said on Tuesday it would take its Elanco animal health business public and posted a better-than-expected quarterly profit, helped by demand for its diabetes drugs Trulicity and Humalog......»»

Category: topSource: reutersJul 24th, 2018

Eli Lilly to take animal health unit public, profit beats estimates

Eli Lilly and Co announced on Tuesday it would take its Elanco animal health business public and posted better-than-expected quarterly profit, helped by demand for its diabetes drugs Trulicity and Humalog......»»

Category: topSource: reutersJul 24th, 2018

Eli Lilly to spin off animal health unit, quarterly profit beats estimates

Eli Lilly and Co announced on Tuesday it would spin off its Elanco animal health business and posted better-than-expected quarterly profit, helped by demand for its diabetes drugs Trulicity and Humalog......»»

Category: topSource: reutersJul 24th, 2018

Eli Lilly spins off animal health unit, second quarter beats

Eli Lilly and Co on Tuesday said it would spin off its Elanco animal health business into a publicly-traded company and posted better-than-expected quarterly profit helped by demand for its diabetes drugs Trulicity and Humalog......»»

Category: topSource: reutersJul 24th, 2018

Eli Lilly updates Trulicity label to show efficacy in CKD, include AWARD-7 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 19th, 2018

Tuberculosis Vaccine Could Reverse Type 1 Diabetes, Study Shows

Just two jabs reverses diabetes even in people who have had the Type 1 form for decades. The causes of Type 1 diabetes can be significantly reversed over several years with just two injections of a common .....»»

Category: europeSource: fortuneJun 21st, 2018

New Diabetes Research for Off-the-Shelf Cell Transplants Shows Promise

Researchers at Georgia Tech found a way to bypass rejection of pancreatic cell transplants by encasing them in a hydrogel shield. Could this challenge the future of insulin injections?Related Stocks: NVO, SNY, LLY, MESO,.....»»

Category: blogSource: gurufocusJun 13th, 2018

Clinical study shows safety, efficacy outcomes for Medtronic Resolute Onyx DES

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 23rd, 2018

AstraZeneca says FASENRA shows consistent safety, sustained efficacy in trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 18th, 2018

CVS Health (CVS) PBM Strengthens, Aetna Deal Shows Promise

A robust 2019 PBM selling season is a tailwind for CVS Health (CVS). Additionally, the company's milestone acquisition of Aetna might alter the whole healthcare landscape in the United States. .....»»

Category: smallbizSource: nytSep 17th, 2018

Novo Nordisk"s Ozempic Lowers Risk of Cardiovascular Events (revised)

Novo Nordisk (NVO) announces post hoc results from SUSTAIN 6 study demonstrating that Ozempic consistently reduces the risk of major cardiovascular (CV) events across type II diabetes population. Novo Nordisk A/S NVO announce.....»»

Category: worldSource: nytSep 4th, 2018

Nemours finishes historic children"s diabetes research

As part of a research project conducted by four institutions across the nation, one Jacksonville hospital is taking part in the next big break in type 1 diabetes treatment. Researchers at Nemours Children's Specialty Care on the Southbank of the S.....»»

Category: topSource: bizjournalsAug 15th, 2018

Covia Holdings" First Earnings Report Shows Some Promise for Investors

There was much to like about the newly formed frack sand and industrial aggregate company, once you allow for the merger-related costs......»»

Category: topSource: foxnewsAug 14th, 2018

Diabetes And Upcoming REWIND Data Key Topics Of Debate For Eli Lilly

Diabetes And Upcoming REWIND Data Key Topics Of Debate For Eli Lilly.....»»

Category: topSource: seekingalphaAug 13th, 2018

Pence Says Return of Remains Shows U.S. Progress on North Korea

Vice President Mike Pence credited North Korean leader Kim Jong Un with fulfilling a promise to return the remains of some U.S. troops killed during the Korean War......»»

Category: asiaSource: wsjAug 2nd, 2018

Eli Lilly Scores a Win in Diabetes

A new study may give sales of one of its diabetes drugs a boost......»»

Category: topSource: foxnewsJul 20th, 2018

J&J"s (JNJ) Phase III Study for Invokana Halted Earlier

Johnson & Johnson's (JNJ) phase III CREDENCE study evaluating the efficacy and safety of its diabetes drug Invokana is being stopped early based on positive pre-specified efficacy data. Johnson & Johnson JNJ .....»»

Category: personnelSource: nytJul 17th, 2018

Next Avenue: This popular diet trend actually shows promise

The research on intermittent fasting indicates it might be a good strategy, even if you’re over 50......»»

Category: topSource: marketwatchJul 16th, 2018

Minerva Shows Cautious Promise Within A Difficult Indication

Minerva Shows Cautious Promise Within A Difficult Indication.....»»

Category: topSource: seekingalphaJul 9th, 2018